Additionally, no growth inhibition was observed with the positive control of 1 mM L-carnitine
Each shipment includes documentation of drug origin, potency testing results, and sterility certification
No (more) backsliding by commercial insurance plans GoodRx reports that tightening criteria in employer-sponsored insurance plans has disqualified an additional 5 million Americans from Zepbound coverage in 2025 vs
We carefully source our ingredients from trusted, reputable suppliers and verify their identity, purity, and potency before use
(3) Amount of Separate Payment for Diagnostic Radiopharmaceuticals Exceeding the Threshold As discussed in the CY 2025 OPPS/ASC final rule with comment period (89 FR 93955 through 93959), once we determine that the per day cost of a nonpass-through diagnostic radiopharmaceutical exceeds the cost threshold, proposed to be $655 per day for CY 2026, we will then assign that radiopharmaceutical to an APC, making it a specified covered outpatient drug (SCOD) per section 1833(t)(14)(B) of the Act
Series A, Biological sciences and medical sciences, 72(1), 127133